citalopram has been researched along with memantine in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (35.00) | 29.6817 |
| 2010's | 9 (45.00) | 24.3611 |
| 2020's | 4 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Alho, H; Juva, K; Lönnqvist, J; Muhonen, LH | 1 |
| Alho, H; Lahti, J; Lönnqvist, J; Muhonen, LH; Sinclair, D | 1 |
| Beattie, K; Hezel, DM; Stewart, SE | 1 |
| Alho, H; Lahti, J; Lönnqvist, J; Muhonen, LH | 1 |
| Alho, H; Haukka, J; Lahti, J; Lönnqvist, J; Muhonen, LH; Saarikoski, ST | 1 |
| Greenway, LL; Kuppuswamy, PS; Lauterbach, EC | 1 |
| Cowen, LG; Cowen, PJ; Harmer, CJ; McTavish, SF; Parsons, E; Pringle, A | 1 |
| D'Antonio, K; Devanand, DP; Harper, OL; Marder, K; Pelton, GH; Roose, SP | 1 |
| Chen, Y; Jiang, J; Long, C; Yang, L; Zahra, A | 1 |
| Ercoli, LM; Grzenda, A; Heimberg, BF; Krause-Sorio, B; Laird, KT; Lavretsky, H; Siddarth, P; Thana-Udom, K; Wu, P; Yeargin, J | 1 |
| Amidzic, A; Tiro, N | 1 |
| Grzenda, A; Laird, KT; Lavretsky, H; Siddarth, P; Yeargin, J | 1 |
| Ercoli, L; Kilpatrick, L; Krause-Sorio, B; Laird, KT; Lavretsky, H; Milillo, MM; Narr, KL; Siddarth, P | 1 |
1 review(s) available for citalopram and memantine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 trial(s) available for citalopram and memantine
| Article | Year |
|---|---|
Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence.
Topics: Adult; Aged; Alcoholism; Ambulatory Care Facilities; Citalopram; Comorbidity; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Agents; Double-Blind Method; Female; Humans; Male; Memantine; Middle Aged; Prevalence; Quality of Life; Receptors, N-Methyl-D-Aspartate; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires | 2008 |
Treatment of alcohol dependence in patients with co-morbid major depressive disorder--predictors for the outcomes with memantine and escitalopram medication.
Topics: Adult; Aged; Alcoholism; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder, Major; Diagnosis, Dual (Psychiatry); Dopamine Agents; Double-Blind Method; Female; Humans; Interview, Psychological; Male; Memantine; Middle Aged; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2008 |
Using an experimental medicine model to understand the antidepressant potential of the N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantine.
Topics: Adolescent; Adult; Antidepressive Agents; Citalopram; Double-Blind Method; Emotions; Excitatory Amino Acid Antagonists; Humans; Male; Memantine; Memory, Short-Term; Neuropsychological Tests; Receptors, N-Methyl-D-Aspartate; Reflex, Startle; Selective Serotonin Reuptake Inhibitors; Young Adult | 2012 |
A Randomized Double-Blind Placebo-Controlled Trial of Combined Escitalopram and Memantine for Older Adults With Major Depression and Subjective Memory Complaints.
Topics: Aged; Citalopram; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Memantine; Memory; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2020 |
Transcriptomic signatures of treatment response to the combination of escitalopram and memantine or placebo in late-life depression.
Topics: Citalopram; Depression; Depressive Disorder, Major; Double-Blind Method; Escitalopram; Humans; Memantine; Transcriptome; Treatment Outcome | 2021 |
Combined treatment with escitalopram and memantine increases gray matter volume and cortical thickness compared to escitalopram and placebo in a pilot study of geriatric depression.
Topics: Adult; Aged; Citalopram; Depression; Double-Blind Method; Female; Gray Matter; Humans; Memantine; Pilot Projects | 2020 |
13 other study(ies) available for citalopram and memantine
| Article | Year |
|---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Memantine as an augmenting agent for severe pediatric OCD.
Topics: Adolescent; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Dopamine Agonists; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Memantine; Obsessive-Compulsive Disorder | 2009 |
Age at onset of first depressive episode as a predictor for escitalopram treatment of major depression comorbid with alcohol dependence.
Topics: Adult; Age of Onset; Aged; Alcoholism; Antidepressive Agents; Citalopram; Comorbidity; Depressive Disorder, Major; Dopamine Agents; Female; Humans; Male; Memantine; Middle Aged; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index | 2009 |
Serotonin transporter polymorphism as a predictor for escitalopram treatment of major depressive disorder comorbid with alcohol dependence.
Topics: Adult; Alcoholism; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder, Major; Female; Gene Frequency; Genotype; Humans; Male; Memantine; Middle Aged; Polymorphism, Genetic; Psychiatric Status Rating Scales; Serotonin Plasma Membrane Transport Proteins | 2011 |
Differential pharmacological responses of catatonia-like signs in frontotemporal dementia.
Topics: Aged; Amantadine; Antipsychotic Agents; Aripiprazole; Benzothiazoles; Catatonia; Citalopram; Clinical Trials as Topic; Dibenzothiazepines; Donepezil; Dopamine Agents; Excitatory Amino Acid Antagonists; Female; Frontotemporal Dementia; Humans; Hypnotics and Sedatives; Indans; Lorazepam; Memantine; Middle Aged; Nootropic Agents; Piperazines; Piperidines; Pramipexole; Quetiapine Fumarate; Quinolones; Selective Serotonin Reuptake Inhibitors | 2010 |
Combined treatment with memantine/es-citalopram for older depressed patients with cognitive impairment: a pilot study.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Citalopram; Cognitive Dysfunction; Depressive Disorder; Dopamine Agents; Drug Therapy, Combination; Female; Humans; Male; Memantine; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales | 2016 |
Memantine rescues prenatal citalopram exposure-induced striatal and social abnormalities in mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Citalopram; Corpus Striatum; Excitatory Amino Acid Antagonists; Female; Interpersonal Relations; Locomotion; Male; Maze Learning; Memantine; Mice; Mice, Inbred C57BL; Pregnancy; Prenatal Exposure Delayed Effects | 2018 |
Kinking of Bilateral Internal Carotid Arteries as Cause of Cognitive Dysfunction.
Topics: Anticholesteremic Agents; Aspirin; Atorvastatin; Bosnia and Herzegovina; Bromazepam; Carotid Artery, Internal; Citalopram; Clopidogrel; Cognitive Dysfunction; Donepezil; Dopamine Agents; Fibrinolytic Agents; GABA Modulators; Humans; Male; Memantine; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2020 |